Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 13

One21: A Novel, Customizable Injection Protocol for Treatment of the Forehead with IncobotulinumtoxinA

Authors de Sanctis Pecora C

Received 6 November 2019

Accepted for publication 21 December 2019

Published 5 February 2020 Volume 2020:13 Pages 127—136


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Jeffrey Weinberg

Video abstract presented by Carla de Sanctis Pecora.

Views: 1962

Carla de Sanctis Pecora

Dermatologie-Clínica, Cirurgia, Cosmiatria e Laser, São Paulo, Brazil

Correspondence: Carla de Sanctis Pecora Avenida Ibirapuera, 2907, Conj. 901, Moema, São Paulo, SP CEP: 04029-200, Brazil
Tel/Fax +55 11 50420871

Abstract: It is well known that incobotulinumtoxinA (INCO) is an effective approved treatment for dynamic wrinkles of the upper face caused by the action of mimetic muscles over time. In doing so, it is important to maintain a balance between muscle groups and a natural facial appearance. Patients differ enormously in their facial anatomy regarding structure and function, both within and between genders, ethnicities, and age. Therefore, treating all patients with the same injection pattern and the same doses can result in undesired outcomes. There is a need for a tailored approach to achieve optimal results, as well as to increase patient satisfaction. With this in mind, the novel one21 injection technique which allows for individualized treatment has been developed for the treatment of horizontal forehead lines using INCO, resulting in a positive impact on eyebrow position and shape. This technique is the next step in a customized approach, giving natural-looking results and high patient satisfaction.

Keywords: incobotulinumtoxinA, botulinum toxin, injection technique, one21, dynamic wrinkles, upper face

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]